Importantly, complementary in silico analysis of the TCGA PRAD cohort confirmed elevated MRPL23 mRNA expression in prostate adenocarcinomas compared with normal tissues, although no significant associations with overall survival were found. Here, MRPL23 is linked to prostate adenocarcinoma.